Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The risks of selective serotonin reuptake inhibitor intake in pregnancy

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Indblik i simuleringsteknik som beslutningsstøtte for COVID-19-interventioner

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Kontinuerlig glukosemonitorering af patienter med type 1- og type 2-diabetes i dialysebehandling

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Svær adenoviruspneumoni hos en immunkompetent mand

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Allergisk kontakteksem ved anvendelse af insulinpumper og glukosesensorer hos børn med diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Remdesivir til behandling af COVID-19-pneumoni

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Low frequency rTMS, inhibits the antidepressive effect of ECT. A pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Stilheden før stormen - om psykiatrisk sygdom i coronaens tid

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transcranial pulsed electromagnetic fields for treatment-resistant depression: A multicenter 8-week single-arm cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Diagnostic added value of electrical source imaging in presurgical evaluation of patients with epilepsy: A prospective study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Depression in pregnancy is common and may have serious consequences for the mother and foetus when untreated. In this review, we discuss selective serotonin reuptake inhibitor (SSRI) intake in pregnancy, which has been associated with increased risk of several unwanted events. However, the evidence indicating a causal relationship between the intake of SSRI in pregnancy and most investigated outcomes is of very low certainty. Confounding by indication likely accounts for most of the observed correlations. If, for any outcomes, an increased risk exists, the number needed to harm is high, and the clinical significance is unclear.

Original languageEnglish
JournalUgeskrift for Laeger
Volume181
Issue number49
ISSN0041-5782
Publication statusPublished - 2 Dec 2019

ID: 58504282